Advanced Medical Solutions Group PLC (AMS), the UK-listed specialist medical device and wound care company, has disclosed that New York-based Glazer Capital, LLC crossed a major shareholding threshold on 2 November 2026. The firm, acting as discretionary investment manager for a group of client funds, now holds 8,324,914 shares, representing 3.766940% of AMS's outstanding shares. The notification was filed with the company on 3 November 2026 and published on 6 November 2026, triggering a formal major holdings disclosure under UK transparency rules. Investors may be watching the development as it signals a new institutional position of meaningful size in the company.

Key Points

  • Advanced Medical Solutions Group PLC (AMS), listed on the London Stock Exchange
  • Glazer Capital, LLC of New York crossed the major shareholding notification threshold on 2 November 2026
  • Glazer Capital holds 8,324,914 shares, equating to 3.766940% of total shares outstanding; no previous notification on record
  • Investors should watch whether Glazer Capital's position increases further, which would require an updated regulatory notification

Glazer Capital Acquires 8.32 Million AMS Shares on Behalf of Client Funds

The announcement confirms that Glazer Capital, LLC, a discretionary investment management firm registered in New York, acquired shares in Advanced Medical Solutions Group PLC, pushing its aggregate holding across client funds above a notifiable threshold. The 8,324,914 shares held are classified entirely as direct equity under ISIN GB0004536594, with no financial instruments or derivatives forming part of the position. The announcement states that Glazer Capital is not controlled by any natural person or legal entity and does not itself control other undertakings holding interests in AMS, though the filing identifies Paul J. Glazer as the ultimate controlling natural person behind Glazer Capital, LLC.

No Prior Major Holding Recorded — This Represents a Fresh Institutional Stake in AMS

The standard notification form indicates no previous major holding notification from Glazer Capital in Advanced Medical Solutions Group, suggesting this represents a newly established institutional position rather than an increment on an existing stake. The threshold was crossed on 2 November 2026, with the issuer notified the following day. Advanced Medical Solutions Group, headquartered in the UK, develops and manufactures advanced wound care and surgical products, operating across international markets. The company did not disclose any commentary on the shareholding change in this announcement, which is standard practice for major holdings notifications of this nature.

Regulatory Context: UK Major Holdings Rules and What the 3.77% Stake Means

Under UK transparency legislation, investors must notify a company and the Financial Conduct Authority when their shareholding crosses defined percentage thresholds, beginning at 3%. Glazer Capital's 3.766940% stake sits just above that initial threshold, meaning any further acquisition pushing the holding above 4% would require a further notification. The disclosure carries no detail on investment intent, holding period, or strategy, as such information is not required under the standard notification framework. Investors monitoring the AMS shareholder register may note that institutional interest from a US-based fund manager represents a development worth tracking in the context of AMS's ongoing commercial strategy.